DCTH (Delcath Systems, Inc.) Pangali Forward P/E
Delcath Systems, Inc. (DCTH) specializes in liver metastasis therapy, generating revenue through the sale of unique isolated drug delivery systems covered by insurance companies. This chart of the current share price reflects a value of 150.90. The positive momentum is driven by a sharp surge in sales of melanoma treatment equipment, while the potential for expanding the network of medical centers has not yet been exhausted.
Ringkesan rincian data analitis Delcath Corp (DCTH)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Delcath Systems, Inc.|DCTH - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Delcath Systems, Inc.|DCTH - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Delcath Systems Inc|DCTH - Utang jangka dawa|Utang jangka cendhak perusahaan Delcath Systems|Rasio cepet delcath.com
- rincian asil keuangan lan kelipatan valuasi:
DCTH - Penghasilan resik|Proyeksi bathi mangsa ngarep Delcath Systems, Inc.|DCTH - Pangali P/E|Prakiraan rega marang bathi Delcath|DCTH - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Delcath Systems Inc|DCTH - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Delcath Systems|DCTH - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan delcath.com|DCTH - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Delcath Systems, Inc.
Ringkesan analitik perusahaan:Delcath Systems
Patent protection for liver chemotherapy systems at Delcath Systems, Inc. (DCTH) makes clinical efficacy the primary value driver. The company's expected P/E multiple compares current market capitalization with projected earnings to measure market optimism. This metric's dynamics reflect the balance between growth potential and the risk of overvaluation. A decrease in the ratio increases the investor's margin of safety. The stability of this metric confirms the fundamental resilience of the business.
Pesaing Delcath Systems, Inc. (DCTH)
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Y-mAbs Corp YMAB|Pangali Forward P/E AURA|candeltx.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E ARAY (Accuray)|SELLAS Life Sciences Group, Inc. (SLS) - Rasio prakiraan rega marang bathi|ACTU - Rega marang bathi mangsa ngarep|CTOR: Rega marang bathi mangsa ngarep|HURA: Pangali Forward P/E|Prakiraan rega marang bathi protaratx.com|FATE (Fate Therapeutics) - Pangali Forward P/E|Pangali Forward P/E Aadi Bio|Prakiraan rega marang bathi TCRX (TScan Therapeutics)|Rasio kapitalisasi marang bathi mangsa ngarep CSBR|Pangali Forward P/E XBIT (XBiotech)|Pangali mangsa ngarep rega marang bathi CVM|OSTX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RADX (radiopharmtheranostics.com)|artivabio.com (ARTV) - Rega marang bathi mangsa ngarep|ANL - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi VERU|Rasio prakiraan rega marang bathi tempesttx.com TPST|Rega marang bathi mangsa ngarep Xilio Therapeutics, Inc. (XLO)|Kapitalisasi marang proyeksi bathi renovarobio.com|Mural Oncology - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep KAPA (Kairos Pharma Limited)|OnKure - Pangali Forward P/E|Rasio prakiraan rega marang bathi CytoMed Therapeutics|curis.com (CRIS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Apollomics|Rega marang bathi mangsa ngarep Tharimmune Corp|Advanced Biomed Corp (ADVB) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi GNPX (Genprex, Inc.)|CLDI (calidibio.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SBFM (Sunshine Biopharma, Inc.)|Kapitalisasi marang proyeksi bathi Xenetic Biosciences Inc. (XBIO)|SLRX - Rega marang bathi mangsa ngarep|PPBT (Kitov Pharma) - Rasio rega marang bathi mangsa ngarep|AONC: Pangali Forward P/E|Prakiraan rega marang bathi beigene.com|Prakiraan rega marang bathi CKPT|elevationoncology.com (ELEV) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E ICAD|ikenaoncology.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E NTBL (Notable Labs, Ltd.)|VIRX - Prakiraan rega marang bathi|MOR: Prakiraan rega marang bathi|NAYA Biosciences Inc - Rasio kapitalisasi marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E
